Pancreatic Enzymes

by Thorne · capsule · 180 capsules

  • On the market (NIH)
  • UPC 6 93749 40102 5
  • DSLD label 328828
  • Serving 1 to 2 capsules; amounts per 2 capsules
  • 90 servings

Pancreatic Enzymes by Thorne lists 0 ingredients. Its current label entered the NIH Dietary Supplement Label Database on June 25, 2025.

What is in Pancreatic Enzymes?

Each row as the label prints it, per serving of 2 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Pancreatic Enzymes: Supplement Facts rows against the market (DSLD label 328828, January 2026 release)
IngredientAmount% DVAmong products listing it
Pancreatinas Amylase, Lipase, PorcineThe Pancreatin in one capsule contains no less than: Amylase 112,500 USP Units, Protease 115,000 USP Units, Lipase 17,500 USP Units.1 g

Source: NIH ODS Dietary Supplement Label Database, label 328828 (entered June 25, 2025), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use: Take 1-2 capsules with each meal or as recommended by your health-care practitioner.
Warnings
Tamper evident: Use only if bottle is sealed.
If pregnant, consult your health-care practitioner before using this product.
Allergens and what it does not contain
Gluten Free
Storage
Store tightly sealed in a cool, dry place.

Source: label statements in DSLD label 328828.

What else is on the label?

Other ingredients: Hypromellose.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): Manufactured in the USA Using US & Imported Ingredients NSF Contents Certified. Listed with: NSF certified (contents or GMP) (a seal is the label's claim; the certifier's own list confirms it).

How many labels does Pancreatic Enzymes have?

2 labels are on file under this name since October 24, 2023: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 328828 (current) Entered June 25, 2025 · on the market · 180 capsules · UPC 6 93749 40102 5
  2. Label 298029 Entered October 24, 2023 · on the market · 180 capsules · UPC 6 93749 40102 5

DSLD also links this label to: Dipan-9 (package size difference, same product), Dipan-9 (image difference, same product), Dipan-9 (package size difference, same product), Dipan-9 (package size difference, same product), Dipan-9 (image difference, same product), Dipan-9 (package size difference, same product), Dipan-9 (image difference, same product), Dipan-9 (package size difference, same product).

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Thorne Research, Inc. (manufacturer). All Thorne products.

Where next?